Login / Signup

Insulin pump therapy, pre-pump hemoglobin A1c and metabolic improvement in children with type 1 diabetes at a tertiary Canadian children's hospital.

Sandra BotrosNazrul IslamBrenden E Hursh
Published in: Pediatric diabetes (2019)
Pre-pump HbA1c appears to play a significant role in the effects of IPT on HbA1c , with the largest decrease in HbA1c seen in the poor pre-pump HbA1c group. Eligibility and consideration for IPT should be expanded to routinely include these children.
Keyphrases
  • adverse drug
  • young adults
  • type diabetes
  • healthcare
  • bone marrow
  • adipose tissue
  • metabolic syndrome
  • cell therapy
  • acute care